Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Arthritis / Rheumatology News

Rheumatoid Arthritis Impacts Millions Of Americans But Remains Severely Underfunded

Main Category: Arthritis / Rheumatology
Also Included In: Bones / Orthopaedics;  Public Health
Article Date: 14 Jul 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:5 stars

5 (4 votes)

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Rheumatoid arthritis (RA) affects 2.1 million Americans and despite many advances in the understanding of the disease, funds for research remain limited and both the cause and a cure are still unknown. The American College of Rheumatology Research and Education Foundation (ACR REF) is working to accelerate RA research and expand financial support of this disease by launching the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign. The new program is designed to raise unprecedented funds to search for a cure.

RA is the most common form of inflammatory arthritis and costs society more than $80 billion each year. The disease affects more than one in every 200 Americans. However, research funding for RA averages as little as $25.90 per patient and remains significantly low compared to other chronic diseases that affect far fewer people like lupus, diabetes and multiple sclerosis, which average $330.00 per patient. Despite the lack of funding, research has led to more effective and aggressive, treatments as well as a better understanding of how to manage the disease.

"Therapy for patients with RA has improved dramatically, and we also have learned that early diagnosis is essential," said Dr. James R. O'Dell, president of the REF. "While there is no cure, patients who receive treatment early feel better and are more likely to lead an active life. Painful symptoms including inflammation and joint damage can be minimized with early treatment and further research will continue to better patients' lives and get us closer to a cure."

Rheumatoid Arthritis Symptoms and Diagnosis

RA is a chronic, autoimmune disease that develops because certain cells of the immune system malfunction and attack healthy joints. It is far more common in women than many expect. Approximately 1 to 3 percent of women may develop RA in their lifetime, which is three times more common in women as in men. While symptoms most often begin between the fourth and sixth decades of life, RA can develop at any age.

Pain, stiffness, swelling, and limitation in the motion and function of multiple joints are the most common symptoms. Though joints are the principal body parts affected by RA, inflammation can develop in other organs as well. Additional warning signs also include:

-- Loss of energy

-- Low-grade fevers

-- Loss of appetite

-- Dry eyes and mouth from an associated condition known as Sjogren's syndrome

-- Firm lumps called rheumatoid nodules beneath the skin in areas such as the elbow and hands

RA can be difficult to diagnose because it may begin gradually and many diseases behave in a manner similar to RA. Patients suspected of having RA should be evaluated by a rheumatologist, a physician with the necessary skill and experience to reach a precise diagnosis and develop the most appropriate treatment plan.

Patients can visit http://www.rheumatology.org/directory to find a rheumatologist in their area.

About Within Our Reach: Finding a Cure for Rheumatoid Arthritis Campaign

Within Our Reach is a national, multi-year fundraising campaign with a goal to raise $30 million towards accelerating innovative research focused specifically on rheumatoid arthritis. It is the largest private fundraising campaign in the REF's history, which will tap a diverse donor base, supporting innovative research to learn more about the causes of RA and, ultimately, to find a cure. Since November, the campaign has received tremendous support from the pharmaceutical industry, biotech companies, physicians and patients.

"Today, more funding needs to be directed towards the kind of RA research that goes beyond treatment only - the kind of RA research that seeks to find a cure through better understanding of the causes of and preventions for this devastating disease," added Dr. O'Dell. "With the guidance of ACR Research and Education Foundation, Within Our Reach will allow more of this type of research to be conducted and together we can work to find a cure."

To learn more about rheumatoid arthritis and Within Our Reach, please visit http://www.WithinOurReach.info.

About the ACR Research and Education Foundation

The ACR Research and Education Foundation was established in 1985 as a 501(c)(3) with a mission to improve patients' lives through support of research and training that advances the prevention, treatment and cure of rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. On average, 90 cents of every dollar donated to the REF is used to fund its extensive award and grant program.

American College of Rheumatology Research and Education Foundation
http://www.WithinOurReach.info




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Lupus Drug Benlysta Effective In Phase 3 Trials
20 Jul 2009
In what has been described as the first lupus drug in decades to show effectiveness in phase 3 clinical trials, the announcement that Benlysta (belimumab) outperformed placebo has surprised Wall Street, where many had...


The Latest on LASIK
The Latest on LASIK

The latest technology gives doctors the ability to map the surface of a patient's eye. That unique map then guides the laser that reshapes the eye. But this technology comes at a price.

more videos are available in our health videos section.